Clinical trial supply chains are constantly evolving, with new technologies and regulations impacting the way that clinical trials are conducted. In a new report, IQPC explores3 key trends that are shaping the way that clinical trials are conducted globally and helping build a resilient and effective clinical trial supply chain.
As industry trends and regulatory changes dramatically alter the speed and path to market for new treatments, these evolving companies need to take a fresh look at their current and future supply chains.
Discover the 5 do's and don'ts when selecting a CMO! The importance of selecting the right CMO/CDMO partnership is critical, as the benefits go beyond significant cost reduction. There is also the potential to improve and develop more strategies for pharmaceutical companies, but only if a mutually collaborative, open and trusting relationship is built.
In 2020 several disruptive events shifted strategic supply chain priorities. An end-to-end approach for supply chain resiliency is imperative to tackle future industry challenges and disruptive events.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.